| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/02/2005 | US20050118222 A macrocyclic lactone (eprinomectin) and antigens against ticks; oily vehicle allows to solubilize the world's first injectable Eprinomectin, in doses of 200-250 mu g/kg of live-weight, with specific tick antigens |
| 06/02/2005 | US20050118221 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound |
| 06/02/2005 | CA2545491A1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 06/01/2005 | EP1534674A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 06/01/2005 | EP1534330A1 Whole bacterial cells as immune modulator |
| 06/01/2005 | EP1534320A2 Apolipoprotein l-i for the treatment or diagnosis of trypanosomal diseases |
| 06/01/2005 | EP1534272A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534242A2 Buccal, polar or non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP0909327B1 Erythromycins and process for their preparation |
| 06/01/2005 | CN1622821A Method of stimulating growth and resistance to diseases of aquatic organisms |
| 06/01/2005 | CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound |
| 06/01/2005 | CN1622811A Use of alkylphosphocholines for the preventative treatment of protozoan diseases |
| 06/01/2005 | CN1204258C Component of bromelain |
| 06/01/2005 | CN1203862C Compound glucose injection with clindamycin and metronidazole |
| 05/31/2005 | US6900195 Administering to a subject an effective amount of a manzamine, manzamine derivative or analog or isomer to treat bacterial, parasitic, viral and other infections |
| 05/31/2005 | US6899890 Bioadhesive drug delivery system |
| 05/31/2005 | CA2216623C Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 05/26/2005 | US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | CA2545182A1 Improved methods and compositions for rna interference |
| 05/25/2005 | EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 05/25/2005 | EP1363654A4 Fab i and inhibition of apicomplexan parasites |
| 05/25/2005 | EP1341791B1 Thioether substituted imidazoquinolines |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620463A Pesticidal spinosyn derivatives |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620421A Substituted alkyl diamine |
| 05/25/2005 | CN1203084C Novel crystalline forms of macrolide antibiotic |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6896891 Non-systemic control of parasites |
| 05/24/2005 | CA2326076C Novel macrolides |
| 05/19/2005 | WO2005044300A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica |
| 05/19/2005 | WO2002069893A3 Treatment of neurological disease |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106202 Endoparasiticidal gel composition |
| 05/19/2005 | CA2545157A1 Disinfecting composition and methods of making and using same |
| 05/19/2005 | CA2544949A1 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 05/18/2005 | EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530427A1 The use of fermented wheat-germ in the feeding and veterinary practice |
| 05/18/2005 | EP1392290B1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
| 05/18/2005 | CN1617863A Thiadiazole compounds and use thereof |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/18/2005 | CN1617733A Method of treatment of gastrointestinal disease and polymeric composition for use therein |
| 05/18/2005 | CN1616430A Rosinyl acridine its producing method and use thereof |
| 05/18/2005 | CN1616101A Novel medicine for treating malaria controlling malaria spreading |
| 05/18/2005 | CN1615988A Antiseptic and insect killing washing liquid and preparing method |
| 05/18/2005 | CN1615854A 奥硝唑泡腾片 Ornidazole effervescent tablets |
| 05/18/2005 | CN1202116C Avermectin derivatives |
| 05/18/2005 | CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/18/2005 | CN1201777C Application of litsea citrate oil in preparing medicine for killing parasite on human body animal |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6893652 Comprises moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silicon dioxide, surfactant, and oil; veterinary medicine |
| 05/17/2005 | US6893651 Synergistic combination of cyclic ketoenol with agonists or antagonists of nicotinic acetylcholine receptors; protecting plants |
| 05/17/2005 | US6893633 Methods and compositions for promoting the maturation of monocytes |
| 05/12/2005 | WO2005002572A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 05/12/2005 | US20050101775 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging |
| 05/12/2005 | US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100532 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |
| 05/11/2005 | EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/11/2005 | EP1528920A1 Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1063992B1 Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations |
| 05/11/2005 | CN1615368A Effectors of innate immunity |
| 05/11/2005 | CN1615127A Substituted bicyclo[3.3.1]nonan-2, 4, 9-triones as pharmaceutical active ingredients |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890527 Methods of treatment |
| 05/06/2005 | CA2543628A1 Multiple active agents such as anthelmintics sustained release delivery |
| 05/05/2005 | US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells |
| 05/05/2005 | US20050095254 DNA immunization against Chlamydia infection |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1109812B1 Pyrrolobenzodiazepines |
| 05/04/2005 | EP0835266B1 Modified/chimeric superantigens and their use |
| 05/04/2005 | CN1612735A Uses for anti-malarial therapeutic agents |
| 05/04/2005 | CN1612688A Anti-pathogenic composition useful in blood preservation |
| 05/03/2005 | US6887906 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 05/03/2005 | US6887869 Mikanolide derivatives, their preparation and therapeutic uses |
| 04/28/2005 | US20050090693 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090459 Crystal forms of azithromycin |
| 04/28/2005 | US20050090452 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |